A breakthrough in the quest to find a blood test for Alzheimer's will help doctors and patients "manage the disease", one of the researchers has said.
Professor Howard Federoff explained:
Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder.
The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention.
Biomarkers such as ours that define this asymptomatic period are critical for successful development and application of these therapeutics.
We consider our results a major step toward the commercialisation of a preclinical disease biomarker test.
More top news
A 17-year-old boy has been charged with the murder of two men in Ipswich.
The X Factor judge praised the One Direction star for his bravery - after performing on the show just days after his mother's death.
At least 13 people have been killed by a car bomb after two explosions went off close to a football stadium in Istanbul.